Ufp Technologies (UFPT) Liabilities and Shareholders Equity (2010 - 2026)

Ufp Technologies (UFPT) posted Liabilities and Shareholders Equity of $674.7 million for Q1 2026, up 2.99% on a QoQ basis from $655.1 million in Q4 2025, and up 4.99% year-over-year from $642.6 million in Q1 2025.

Ufp Technologies (UFPT) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends

Ufp Technologies' Liabilities and Shareholders Equity history runs 17 years deep, the most recent figure standing at $674.7 million for Q1 2026.

  • Quarterly Liabilities and Shareholders Equity rose 4.99% year-over-year to $674.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.6 billion (up 12.21% YoY) and the FY2025 annual result came in at $655.1 million, up 4.15% from the prior year.
  • Liabilities and Shareholders Equity was $674.7 million for Q1 2026 at Ufp Technologies, up from $655.1 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $674.7 million in Q1 2026 and bottomed at $363.3 million in Q1 2022.
  • A 5-year average of $498.5 million and a median of $407.7 million in 2024 frame the typical range for Liabilities and Shareholders Equity.
  • Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity soared 81.81% — and 2023, when it climbed 0.74%.
  • Ufp Technologies' Liabilities and Shareholders Equity stood at $378.2 million in 2022, then climbed by 6.86% to $404.1 million in 2023, then jumped by 55.64% to $629.0 million in 2024, then climbed by 4.15% to $655.1 million in 2025, then increased by 2.99% to $674.7 million in 2026.
  • Business Quant data shows UFPT's Liabilities and Shareholders Equity at $674.7 million in Q1 2026, $655.1 million in Q4 2025, and $652.8 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 110.43 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 46.29 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 93.03 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 44.35 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 13.32 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 6.63 Bn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 31.92 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 37.13 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn - 10.46 Bn
10 Ufp Technologies 1.82 Bn 1.80 Bn 44.36 Mn 674.68 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 674.68 Mn
Dec 31, 2025 655.08 Mn
Sep 30, 2025 652.82 Mn
Jun 30, 2025 634.66 Mn
Mar 31, 2025 642.64 Mn
Dec 31, 2024 629.00 Mn
Sep 30, 2024 638.51 Mn
Jun 30, 2024 422.40 Mn
Mar 31, 2024 407.68 Mn
Dec 31, 2023 404.14 Mn
Sep 30, 2023 399.81 Mn
Jun 30, 2023 397.99 Mn
Mar 31, 2023 390.78 Mn
Dec 31, 2022 378.19 Mn
Sep 30, 2022 388.32 Mn
Jun 30, 2022 395.05 Mn
Mar 31, 2022 363.35 Mn
Dec 31, 2021 334.13 Mn
Sep 30, 2021 220.69 Mn
Jun 30, 2021 217.29 Mn